Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 02:14:01 - browse：8347

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Prescription digital therapeutics are key to pharma’s future

focus

WSS

My daughter's legacy lives on through her writing, phage therapy

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Readers discuss the intersection of pregnancy and addiction

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

NIH tests clinical research in primary care with $30 million program

Wikipedia

Wikipedia

knowledge

At least 13 dead in Texas as scorching temps continue

Dexcom's push to bring CGM to type 2 diabetes patients

Jerome Adams on the need for new antivirals for Covid

Fatty liver disease was alleviated by Lilly’s ‘triple

State Dept. review finds Biden bears some blame for Afghanistan failures

Crowdfunding for unproven stem cell procedures spreads misinformation

Medicare details structure of new drug price negotiation program

Fatty liver disease was alleviated by Lilly’s ‘triple

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Lilly's Alzheimer's drug donanemab backed by FDA advisers

entertainment

A letter from the executive editor: The 2023 STATUS List

UpToDate has a racism problem: Dr. Stanley Goldfarb

Undocumented workers face uncertainty as immigration law takes effect in Florida

What affirmative action's end means to a medical student

Curing rare childhood diseases will falter unless Congress steps up

New report analyzes digital physical therapy solutions' effectiveness

knowledge

focus

Wikipedia

entertainment